Efficacy and safety of retreatment with vedolizumab in patients with ulcerative colitis

被引：0
|
作者：
Sands, B. E. [1 ]
Shafran, I. [2 ]
Farraye, F. A. [3 ]
Cheifetz, A. S. [4 ]
Abhyankar, B. [5 ]
Sankoh, S. [6 ]
Smyth, M. [7 ]
机构：
[1] Mt Sinai Hosp, Icahn Sch Med, Gastroenterol, New York, NY 10029 USA
[2] Shafran Gastroenterol Ctr, Gastroenterol, Winter Pk, FL USA
[3] Boston Med Ctr, Gastroenterol, Boston, MA USA
[4] Beth Israel Deaconess Med Ctr, Med, Boston, MA 02215 USA
[5] Takeda Global Res & Dev Ctr Europe Ltd, Clin Sci, London, England
[6] Takeda Pharmaceut Int Co, Stat, Cambridge, MA USA
[7] Takeda Global Res & Dev Ctr Europe Ltd, Med, London, England
来源：
JOURNAL OF CROHNS & COLITIS | 2015年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
DOP028
引用
收藏
页码：S37 / S37
页数：1
相关论文
共 50 条
  • [21] EFFICACY AND SAFETY OF VEDOLIZUMAB IN THE TREATMENT OF ULCERATIVE COLITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Thode, R.
    Veeranki, P.
    Inuganti, A.
    Paladugu, G.
    Hyderboini, R. K.
    Kolapalli, N.
    Vsn, M.
    Dang, D.
    Dang, A.
    VALUE IN HEALTH, 2018, 21 : S82 - S82
  • [22] The safety of vedolizumab for ulcerative colitis and Crohn's disease
    Colombel, Jean-Frederic
    Sands, Bruce E.
    Rutgeerts, Paul
    Sandborn, William
    Danese, Silvio
    D'Haens, Geert
    Panaccione, Remo
    Loftus, Edward V., Jr.
    Sankoh, Serap
    Fox, Irving
    Parikh, Asit
    Milch, Catherine
    Abhyankar, Brihad
    Feagan, Brian G.
    GUT, 2017, 66 (05) : 839 - 851
  • [23] Efficacy of vedolizumab (VDZ) by disease extension in ulcerative colitis
    Michetti, P.
    Braegger, F.
    Kempf, C.
    Allez, M.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S402 - S403
  • [24] Long-term Efficacy of Vedolizumab for Ulcerative Colitis
    Loftus, Edward V., Jr.
    Colombel, Jean-Frederic
    Feagan, Brian G.
    Vermeire, Severine
    Sandborn, William J.
    Sands, Bruce E.
    Danese, Silvio
    D'Haens, Geert R.
    Kaser, Arthur
    Panaccione, Remo
    Rubin, David T.
    Shafran, Ira
    McAuliffe, Megan
    Kaviya, Arpeat
    Sankoh, Serap
    Mody, Reema
    Abhyankar, Brihad
    Smyth, Michael
    JOURNAL OF CROHNS & COLITIS, 2017, 11 (04): : 400 - 411
  • [25] Safety and efficacy of vedolizumab in the treatment of patients with moderate to severe Ulcerative Colitis: a systematic review and meta-analysis
    Khorshid, M.
    Alboraie, M.
    Abbas, W.
    Sayed, Z. E.
    El-Nady, M.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S516 - S517
  • [26] Comparative efficacy of JAK inhibitors versus vedolizumab in patients with hypoalbumineamia and Ulcerative colitis
    Pearman, K.
    Saini, V.
    Vincent, S.
    Rhodes, S.
    Harvey, P.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1621 - I1621
  • [27] Comparative Efficacy of Vedolizumab and Adalimumab in Ulcerative Colitis Patients Previously Treated With Infliximab
    Favale, Agnese
    Onali, Sara
    Caprioli, Flavio
    Pugliese, Daniela
    Armuzzi, Alessandro
    Macaluso, Fabio Salvatore
    Orlando, Ambrogio
    Viola, Anna
    Fries, Walter
    Rispo, Antonio
    Castiglione, Fabiana
    Mocci, Giammarco
    Chicco, Fabio
    Usai, Paolo
    Calabrese, Emma
    Biancone, Livia
    Monteleone, Giovanni
    Fantini, Massimo Claudio
    INFLAMMATORY BOWEL DISEASES, 2019, 25 (11) : 1805 - 1812
  • [28] Histologic Outcomes With Vedolizumab Versus Adalimumab in Ulcerative Colitis: Results From An Efficacy and Safety Study of Vedolizumab Intravenous Compared to Adalimumab Subcutaneous in Participants With Ulcerative Colitis (VARSITY)
    Peyrin-Biroulet, Laurent
    Loftus, Edward V., Jr.
    Colombel, Jean-Frederic
    Danese, Silvio
    Rogers, Raquel
    Bornstein, Jeffrey D.
    Chen, Jingjing
    Schreiber, Stefan
    Sands, Bruce E.
    Lirio, Richard A.
    GASTROENTEROLOGY, 2021, 161 (04) : 1156 - +
  • [29] Tofacitinib, vedolizumab and ustekinumab in patients with ulcerative colitis
    Chang, Hui-Chin
    Gau, Shuo-Yan
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 58 (11-12) : 1242 - 1242
  • [30] Vedolizumab in the Treatment of Ulcerative Colitis: An Evidence-Based Review of Safety, Efficacy, and Place of Therapy
    Takatsu, Noritaka
    Hisabe, Takashi
    Higashi, Daijiro
    Ueki, Toshiharu
    Matsui, Toshiyuki
    CORE EVIDENCE, 2020, 15 : 7 - 20
12345